Indian CKD Registry launched
The CKD Registry of India begins multi-centre data collection that becomes the first national picture of the disease pattern.
Chronic kidney disease affects an estimated 220 million Indians. 90 percent don't know they have it. By the time symptoms appear, 60 to 80 percent of kidney function is gone. Dialysis costs.
Audio version coming soon
Chronic kidney disease is India's quietest big disease. Multi-centre Indian CKD Registry data and the SEEK-India study estimate that 16 to 17 percent of Indian adults have some stage of chronic kidney disease, which translates to roughly 22 crore people. Most never know until they reach stage 4 or 5, when more than 60 percent of kidney function is already lost and dialysis or transplantation is the only option left. Diabetes and hypertension cause the majority of cases, but India also has unique pockets of CKDu, chronic kidney disease of unknown origin, in Andhra Pradesh, Odisha and parts of Karnataka, often striking young farm workers. Dialysis in private centres costs 1,500 to 4,000 rupees a session, three times a week, and a kidney transplant runs 8 to 15 lakh rupees. The Pradhan Mantri National Dialysis Programme helps, but supply is far short of need.
India's CKD numbers rise from a stack of causes. Diabetes is the biggest, since 30 to 40 percent of long-standing diabetics develop diabetic nephropathy. Hypertension is the second pillar, and 28 percent of Indian adults have high BP with most going untreated. Painkiller misuse adds the third layer. Easy over-the-counter access to diclofenac and ibuprofen, combined with self-medication for body ache and back pain in physical jobs, slowly damages the renal tubules. Long-term exposure to ayurvedic preparations that contain heavy metals can also cause renal injury. In agricultural districts of Andhra Pradesh, Odisha and parts of Karnataka, a distinct disease called CKDu strikes young farm workers without diabetes, linked to a mix of dehydration, heat stress and possible agrochemical exposure. Late diagnosis is then the killer multiplier. Routine urine and creatinine testing remains rare at primary health centres, so the kidney loses 60 to 80 percent of its function before symptoms show.
Unread picks stay on top. Fresh stories may appear as they are ready โ no extra loading.
India now has 12 million obese children under 19, according to ICMR data. School canteens sell junk food while ultra-processed food advertising targets children.
India collects only 11 million units of blood annually against a need of 15 million. The O-negative shortage is acute, urban blood banks run on single-day reserves, and the rural gap is catastrophic.
India has fewer sports medicine doctors than many US college programs. Cricket and marathons grew fast; specialist care did not, so preventable injuries end careers early.
Biosimilars โ cheaper copies of complex biological drugs โ are worth 50 billion globally. Indian companies are racing to capture that market, threatening to cut the price of cancer and.
Micronutrient gaps hit rich and poor: anaemia stays high, vegetarians often lack B12, and urban adults lack vitamin D. Fortification and better diets can bend the curve if delivery improves.
127 essential medicines are out of stock in government hospitals across 12 states. The shortage hits insulin, antibiotics and cancer drugs. Central procurement failure exposes PM Jan Aushadhi gaps.
Key statistics on Indian CKD:
Myth 1: If urine looks normal, the kidneys are fine. Fact: Kidney disease progresses silently for years before urine changes. The standard tests are blood creatinine with estimated GFR and a urine albumin to creatinine ratio. A normal urine colour means nothing if eGFR is dropping. Anyone with diabetes, hypertension or a family history should test annually.
Myth 2: Drinking lots of water cures kidney problems. Fact: Adequate hydration is good for healthy kidneys, but a patient with established CKD or heart failure needs a doctor-set fluid limit. Drinking 4 to 5 litres a day in advanced kidney disease can cause dangerous fluid overload and pulmonary oedema.
Myth 3: Once you are on dialysis you are finished. Fact: Dialysis is a long bridge, not a death sentence. Many Indian patients live decades on maintenance haemodialysis, and home-based peritoneal dialysis has dramatically improved quality of life. A successful transplant, even from a living donor, can give 10 to 20 productive years. The real enemy is late diagnosis, not the treatment itself.
Take Ramesh Reddy, a 47-year-old auto driver in Hyderabad diagnosed with end-stage kidney disease in 2023. He now spends 12 hours a week on dialysis at the district hospital under PMNDP. The dialysis is free but transport, medication and dietary supplements still cost his family 8,000 rupees a month, more than a quarter of household income. His wife had to leave domestic work to be his caregiver. Across India, kidney patients carry a triple burden. There is the disease itself, the cost of repeated travel, and the loss of working hours. In CKDu hotspots like Uddanam in Andhra Pradesh, entire villages have lost younger men, and women carry farms, children and dialysis trips at once. Transplant offers a way back but the wait list is long, organ donation rates are minimal and many families face exploitative offers from middlemen. The emotional cost, the dialysis chairs that fill at every shift and the children growing up with a parent permanently tired are the unmeasured weight of this disease.
The bigger meaning of India's CKD numbers is that the country has built a hospital response without a screening foundation. Dialysis chairs and transplant centres are growing, but blood pressure control, diabetes management and routine urine testing at primary care remain weak. The long-term consequence is that India will keep producing kidney failure faster than it can treat. Each new dialysis patient is a family-level economic shock and a national fiscal cost through PMNDP. The lesson from Mexico, which scaled up annual eGFR screening in primary care, is that catching CKD at stages 1 to 3 can delay or prevent dialysis for years and saves money. India's future depends on whether Health and Wellness Centres routinely test creatinine and urine albumin in diabetics and hypertensives, whether painkiller misuse is curbed, and whether CKDu hotspots get clean water and heat protection. Otherwise the silent epidemic will keep stealing breadwinners and savings from millions of families.
Chronology
Follow the arc from background to turning points. On mobile, swipe the cards and use the step rail below; on desktop, use the spine to jump.
The CKD Registry of India begins multi-centre data collection that becomes the first national picture of the disease pattern.
The Screening and Early Evaluation of Kidney Disease India study finds CKD prevalence at around 17 percent of adults, much higher than previously assumed.
ICMR launches systematic investigation into the chronic kidney disease cluster in Uddanam, Andhra Pradesh, where prevalence in adult men exceeds 30 percent.
Pradhan Mantri National Dialysis Programme begins free haemodialysis services at district hospitals using a public-private partnership model.
Joint analysis confirms diabetic nephropathy as the largest single driver of new ESRD in India and pushes for diabetic kidney screening.
PMNDP brings continuous ambulatory peritoneal dialysis into the public package, expanding home-based options for stable patients.
Government announces PMNDP has crossed 1 crore haemodialysis sessions in a year, but unmet demand for new dialysis seats remains acute.
Step 1/7 events
Understand why it happened, how we got here, and what might come next.